Rice Hall James & Associates »

Peregrine Pharmaceuticals shares owned by Rice Hall James & Associates

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Rice Hall James & Associates from 13F filings

Historical chart of Rice Hall James & Associates investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Rice Hall James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Rice Hall James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.6M 391k 6.70
2023-12-31 $2.6M 407k 6.50
2023-09-30 $2.4M 252k 9.44
2023-06-30 $3.5M 253k 13.97